Pier Luigi Temporelli
Overview
Explore the profile of Pier Luigi Temporelli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
134
Citations
1391
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gil Ad V, Di Fusco S, Manes M, Scardovi B, Pavan D, Pariggiano I, et al.
G Ital Cardiol (Rome)
. 2025 Feb;
26(3):147-158.
PMID: 39998343
The impact of hormone replacement therapy (HRT) on the cardiovascular (CV) system in menopausal women has been the subject of significant debate for many years. After a phase marked by...
2.
Temporelli P
Eur Heart J Suppl
. 2025 Feb;
27(Suppl 1):i1-i5.
PMID: 39980783
Cardiovascular (CV) diseases (CVDs) remain a leading global health issue, causing about one-third of all deaths worldwide. Among modifiable CV risk factors (systolic blood pressure, non-HDL cholesterol, diabetes, body mass...
3.
Temporelli P, Di Pasquale G, De Caterina R
G Ital Cardiol (Rome)
. 2025 Feb;
26(2):85-89.
PMID: 39898738
No abstract available.
4.
Pistono M, Giordano A, Gnemmi M, Gambarin F, Granata M, Imparato A, et al.
Artif Organs
. 2025 Jan;
PMID: 39797411
Background: Left Ventricular Assist Device (LVAD) implantation is an important treatment option for patients with advanced CHF. Referral to an early, intensive cardiac rehabilitation (CR) program in these patients seems...
5.
Binaghi G, Abrignani M, Temporelli P, Casula M, Maloberti A, Riccio C, et al.
G Ital Cardiol (Rome)
. 2024 Dec;
26(1):50-60.
PMID: 39714500
Potassium is the most represented intracellular electrolyte in the human body. Its extracellular levels are maintained within strict limits through different mechanisms, which constitute the homeostasis of potassium. Hyperkalemia is...
6.
Di Pasquale G, Temporelli P
G Ital Cardiol (Rome)
. 2024 Dec;
26(1):17-19.
PMID: 39714494
No abstract available.
7.
Maloberti A, Colombo V, Daus F, De Censi L, Abrignani M, Temporelli P, et al.
Nutr Metab Cardiovasc Dis
. 2024 Dec;
35(3):103792.
PMID: 39674722
Aims: The most frequent consequence of elevated uric acid (UA) levels is the development of gout and urate kidney disease. Besides these effects, several studies have investigated the association between...
8.
Mojoli M, Temporelli P, Pavan D, Abrignani M, Gonzini L, Lucci D, et al.
J Cardiovasc Med (Hagerstown)
. 2024 Nov;
25(12):845-853.
PMID: 39499661
Aims: The impact of sex-related factors on current clinical management and outcomes of chronic coronary syndromes (CCS) are unclear. Methods: All patients belonging to the prospective, nationwide START registry were...
9.
Zuin M, Corsini A, Dalla Valle C, De Rosa C, Maloberti A, Mojoli M, et al.
Eur Heart J Cardiovasc Pharmacother
. 2024 Oct;
10(8):719-724.
PMID: 39406397
Proprotein convertase subtilisin/kexin type 9 inhibitors (PCSK9i) have recently emerged as promising therapeutic agents for lowering low-density lipoprotein cholesterol and reducing the risk of cardiovascular events. Moreover, preliminary evidence from...
10.
Ciliberti G, Abrignani M, Zilio F, Temporelli P, Ciccirillo F, Fortuni F, et al.
G Ital Cardiol (Rome)
. 2024 Jul;
25(8):546-556.
PMID: 39072593
The consumption of energy drinks (ED) has become a growing public health issue, since potentially ED-related serious adverse cardiovascular events, including arrhythmias, myocardial infarction, cardiomyopathies, and sudden cardiac death, have...